Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242764 (US10030025, Compound 30 | US10836768, Cpd no 30 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 7 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112180 (CHEMBL3608688 | US10030025, Compound 41 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | 11 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242740 (US10030025, Compound 1 | US10836768, Cpd no 1 | US...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 11 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242741 (US10030025, Compound 2 | US10836768, Cpd no 2 | US...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 15 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112181 (CHEMBL3608687 | US10030025, Compound 3 | US1083676...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | US Patent | 19 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242742 (US10030025, Compound 4 | US10836768, Cpd no 4 | US...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 20 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112244 (CHEMBL3608680 | US10030025, Compound 5 | US1083676...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Similars | US Patent | 23 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242743 (US10030025, Compound 6 | US10836768, Cpd no 6 | US...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 24 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242744 (US10030025, Compound 7 | US10836768, Cpd no 7 | US...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 26 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242772 (US10030025, Compound 38 | US10836768, Cpd no 38 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 26 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242745 (US10030025, Compound 8 | US10836768, Cpd no 8 | US...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 26 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242773 (US10030025, Compound 39 | US10836768, Cpd no 39 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 28 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242746 (US10030025, Compound 9 | US10836768, Cpd no 9 | US...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 30 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242747 (US10030025, Compound 10 | US10836768, Cpd no 10 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 31 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112245 (CHEMBL3608741 | US10030025, Compound 11 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | US Patent | 32 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242768 (US10030025, Compound 34 | US10836768, Cpd no 34 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 38 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242749 (US10030025, Compound 13 | US10836768, Cpd no 13 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 40 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242771 (US10030025, Compound 37 | US10836768, Cpd no 37 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 41 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242750 (US10030025, Compound 14 | US10836768, Cpd no 14 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 42 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242770 (US10030025, Compound 36 | US10836768, Cpd no 36 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 43 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242751 (US10030025, Compound 15 | US10836768, Cpd no 15 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 45 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242777 (US10030025, Compound 44 | US10836768, Cpd no 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 45 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242775 (US10030025, Compound 42 | US10836768, Cpd no 42 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 48 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242752 (US10030025, Compound 16 | US10836768, Cpd no 16 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 49 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242753 (US10030025, Compound 17 | US10836768, Cpd no 17 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 51 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242754 (US10030025, Compound 18 | US10836768, Cpd no 18 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 54 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242755 (US10030025, Compound 19 | US10836768, Cpd no 19 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 56 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242748 (US10030025, Compound 12 | US10836768, Cpd no 12 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 59 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242776 (US10030025, Compound 43 | US10836768, Cpd no 43 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 59 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242766 (US10030025, Compound 32 | US10836768, Cpd no 32 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 59 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112179 (CHEMBL3608740 | US10030025, Compound 20 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | 60 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242756 (US10030025, Compound 21 | US10836768, Cpd no 21 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 63 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242757 (US10030025, Compound 22 | US10836768, Cpd no 22 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 69 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242765 (US10030025, Compound 31 | US10836768, Cpd no 31 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 70 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242769 (US10030025, Compound 35 | US10836768, Cpd no 35 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 73 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242759 (US10030025, Compound 24 | US10836768, Cpd no 24 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 78 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM280769 (US10030025, Compound 45-2 | US10836768, Cpd no 45-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 83 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242774 (US10030025, Compound 40 | US10836768, Cpd no 40 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 83 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242760 (US10030025, Compound 25 | US10836768, Cpd no 25 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 85 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242761 (US10030025, Compound 26 | US10836768, Cpd no 26 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 88 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242767 (US10030025, Compound 33 | US10836768, Cpd no 33 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 89 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM280768 (US10030025, Compound 45-1 | US10836768, Cpd no 45-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 100 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242762 (US10030025, Compound 27 | US11731974, Compound 27 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 100 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242778 (US10030025, Compound 45 | US10836768, Cpd no 45 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 101 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50112243 (CHEMBL3608682 | US10030025, Compound 28 | US108367...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | 110 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM242758 (US10030025, Compound 23 | US10836768, Cpd no 23 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 150 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM280751 ((R)-4-(8-methyl-3-(3-methyl- 1,2,4-thiadiazol-5-yl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 150 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Substance-K receptor (Homo sapiens (Human)) | BDBM242740 (US10030025, Compound 1 | US10836768, Cpd no 1 | US...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 7.50E+3 | -29.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 receptor. Membra... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Substance-P receptor (Homo sapiens (Human)) | BDBM242740 (US10030025, Compound 1 | US10836768, Cpd no 1 | US...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.03E+4 | -28.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the NK-1 receptor was evaluated in CHO recombinant cells which express the human NK-1 receptor. Membra... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Substance-P receptor (Homo sapiens (Human)) | BDBM242742 (US10030025, Compound 4 | US10836768, Cpd no 4 | US...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.99E+4 | -26.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
OGEDA SA US Patent | Assay Description The affinity of compounds of the invention for the NK-1 receptor was evaluated in CHO recombinant cells which express the human NK-1 receptor. Membra... | US Patent US10030025 (2018) BindingDB Entry DOI: 10.7270/Q2B56MSG | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 205 total ) | Next | Last >> |